Business Wire

THE NUVISAN GROUP Continues Its Growth by Adding Parts of the GALDERMA R&D Capabilities from NESTLÉ SKIN HEALTH

Jaa

On August 31st the NUVISAN GROUP, one of Europe´s leading CRO´s focused on early stage drug development for the life science industry, signed an agreement with NESTLÉ SKIN HEALTH/ GALDERMA to take over parts of the R&D capacities in Sophia-Antipolis, France.

The GALDERMA R&D site in Sophia-Antipolis which opened in 2006 is the world’s largest research and development center focused on medical and cosmetic solutions for the skin. The new capabilities will strengthen NUVISAN’S core service lines in Bioanalysis, Clinical Trial Supplies and Pharmaceutical Analytics as well as enhancing the portfolio by adding GMP-API synthesis and formulation capability for prescription drugs and cosmetics. NUVISAN intends to start its operations in Sophia Antipolis in October 2018.

NUVISAN thus underscores its claim to becoming Europe’s leading one-stop pharma services provider in the field of early stage drug development for the pharmaceutical industry with its third acquisition since 2011. The integration of parts of the former GALDERMA R&D will add 80 employees to NUVISAN's existing 325 employees to give 400+ employees in the NUVISAN GROUP.

"With these new R&D capabilities and capacities, we not only integrate a high-performance team, but also obtain access to a great deal of specialty know-how which we can bundle directly into the NUVISAN GROUP, enabling us to significantly increase and enhance benefits to our customers " says CEO of NUVISAN, Dr. Dietrich Bruchmann.

NUVISAN is now able to significantly accelerate the drug development process from discovery to clinical trials for clients.

With these new capacities, NUVISAN expertise will be extended to the fields of chemistry, liquid and semi-solid formulation development whilst creating an operational hub in close proximity to Southern European customers.

About NUVISAN

The owner-managed NUVISAN GROUP generates sales of approx. € 40 million with currently over 300 highly qualified employees. It originated from LAB AAI Pharma 40 years ago and has been operating under the name NUVISAN GmbH with its headquarters in Neu-Ulm since 2010. With the addition of the new R&D capacities, the headcount will increase by more than 20% and brings NUVISAN to app. 400+ employees.

Contact information

NUVISAN
Dr. rer. medic. David Surjo
Executive Vice President Pharmaceutical Services
Phone: +49 731 9840 235 / +49 162 4061 836
Email: david.surjo@nuvisan.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

SailPoint Survey Shows Employees’ Habits Expose Growing Risk Amid the Digital Transformation13.11.2018 09:01Tiedote

The results of the 10th Annual Market Pulse Survey from SailPoint Technologies Holdings, Inc. (NYSE: SAIL), the leader in enterprise identity governance, expose an alarming trend: despite an increased focus on cybersecurity awareness in the workplace, employees’ poor cybersecurity habits are getting worse, compounded by the speed and complexity of the digital transformation. Of the 1,600 global employees surveyed, 75% of respondents admitted to reusing passwords across accounts, including work and personal, compared to 56% who admitted to doing so in 2014, when SailPoint first posed the question. For more key findings, view the infographic, Balancing Efficiency and Security in Today’s Enterprises . Organizations are at varying stages of the digital transformation, and that evolution has presented an increasingly complex IT environment to manage securely. Yet this years’ Market Pulse Survey findings points to a workforce who are less committed to security best practices. This has not on

Biometric experts iProov support UK Home Office with technology to assure genuine presence13.11.2018 03:01Tiedote

iProov, a leading provider of biometric facial verification technology, today announced that it will play a key role in a multi-year contract with the UK Home Office for the provision of smartphone-based digital identity verification. This new capability will assist the UK Home Office in delivering secure, easy-to-use interactions with individuals in accordance with the digital services agenda. The app to support applications for the EU Exit Settlement Scheme includes this technology. The new digital service, which will be provided in partnership with immigration and border management company WorldReach Software with support from Dutch contactless document specialist ReadID, allows secure enrolment onto Home Office services using a smartphone app. The process involves biometric matching of the user’s selfie against the image read from a user’s passport chip, using iProov’s unique Flashmark technology to provide robust liveness detection. iProov is unique in its ability to ‘assure genui

Project Management Institute Launches New Reports on Navigating the New Normal of Disruptive Technologies During Seventh Annual PMO Symposium®12.11.2018 19:43Tiedote

Project Management Institute (PMI) today unveiled three thought leadership reports focused on navigating the new normal of disruptive technologies. The new reports were released during the organization’s seventh annual PMO Symposium® in Washington D.C., where more than 650 of the world’s top project management office (PMO) executives, organizational leaders and senior decision makers have gathered to discuss how disruptive technologies—such as cloud solutions, internet of things (IoT) and artificial intelligence (AI)—have changed the way organizations do business and transformed entire industries. Throughout 2018, PMI and partners, have been exploring disruptive technologies and how organizations are using them to achieve their goals in these changing times. While no one single factor can drive benefits realization, leading organizations understand that proven project management practices lead to greater success and less waste. Produced in partnership with Accenture, PMI’s report — For

Separate Independent Studies Found that PREVENA™ Therapy Reduced Complications Following Breast Cancer Surgery and Breast Reconstruction12.11.2018 17:00Tiedote

KCI, an Acelity Company, announced today that recently published data stemming from two studies demonstrate that closed incision negative pressure therapy (ciNPT) with the PREVENA™ Incision Management System reduced postsurgical wound complication potential in patients recovering from oncological breast surgery and breast reconstruction, respectively. One study titled, “The Impact of Closed Incision Negative Pressure Therapy on Postoperative Breast Reconstruction Outcomes,” showed that patients who received ciNPT with the PREVENA™ System had significantly lower rates of overall complications and returns to the operating room compared to those in the standard of care (SOC) for incision management after breast reconstruction post-mastectomy group. In addition, patients in the PREVENA™ Therapy group overall had a shorter mean time to complete removal of all drains than the SOC group, averaging 9.9 days versus 13.1, respectively.1 In a separate study titled, “Closed Incision Negative Press

Itron Invites Innovators to Participate in Smart City Challenge12.11.2018 16:45Tiedote

Itron, Inc. (NASDAQ: ITRI) is calling for hardware and software vendors to submit their products and solutions to the inaugural Itron Smart City Challenge. IoT solution providers will compete for the chance to work with leading smart cities, including Glasgow and the City of London, to deploy breakthrough solutions. Applications are due by Jan. 4, 2019. Participants are invited to develop solutions to address challenges defined by the participating cities. Glasgow: Improve travel choices and experience during events in the city while promoting the overall city center offer The City of Glasgow is one of the world’s top sporting cities and a major destination for conferences and concerts. Many thousands of people come to the city on a regular basis to experience its year-round calendar of events. However, this brings significant challenges in getting people safely and conveniently around the city to their location. It also impacts residents and particularly, the public transport system.

US-Based Lineage Logistics Acquires UK Cold Storage, Frozen Food and Logistics Service Provider Yearsley Group12.11.2018 15:00Tiedote

Lineage Logistics Holdings, LLC (“Lineage” or the “Company”), the world’s most innovative and trusted provider of temperature-controlled supply chain solutions, today announced it has acquired Yearsley Group Limited (“Yearsley”), a leading temperature-controlled logistics service provider and frozen food distributor in the UK. Financial terms of the transaction were not disclosed. “Yearsley has demonstrated a strong commitment to developing longstanding, bespoke customer relationships that is consistent with how we do business at Lineage. Bringing Yearsley into the Lineage family enables us to better serve customers in the UK market and further reinforces our international logistics capabilities,” said Greg Lehmkuhl, President and Chief Executive Officer of Lineage Logistics. “Our acquisition by Lineage is a tremendous opportunity for Yearsley customers and employees alike,” said Jonathan Baker, Chief Executive of Yearsley Group. “Lineage’s commitment to innovation and service is unmat

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme